Tobacco cessation treatment pathways for patients with cancer: 10 years in the making

Maher Karam-Hage, Hanadi Ajam Oughli, Vance Rabius, Diane Beneventi, Rosario C. Wippold, Janice A. Blalock, Paul M. Cinciripini

Research output: Contribution to journalReview articlepeer-review

32 Scopus citations

Abstract

Tobacco use is the most common cause of preventable morbidity and mortality in the United States; it accounts for one-third of all cancer deaths and is thought to account for half of preventable cancer deaths. This article describes the Tobacco Treatment Program at a major academic cancer center. Patients and employees may access these services in a number of ways. All current smokers and recent quitters are proactively contacted and invited to participate. Services provided are tailored to the motivational level of individual patients and their immediate medical needs. The treatment pathways we present are based on our experience from the last 10 years in treating more than 5,000 unique patients with around 60,000 patient visits. These pathways include behavioral counseling and pharmacotherapy, including first-line, second-line, and off-label medication use. This article describes the program with the goal of providing guidance and ideas to others who are developing treatment programs and providing treatment to tobacco users.

Original languageEnglish (US)
Pages (from-to)1469-1477
Number of pages9
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume14
Issue number11
DOIs
StatePublished - Nov 1 2016

ASJC Scopus subject areas

  • Oncology

MD Anderson CCSG core facilities

  • Clinical Trials Office

Fingerprint

Dive into the research topics of 'Tobacco cessation treatment pathways for patients with cancer: 10 years in the making'. Together they form a unique fingerprint.

Cite this